ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RUNX1
|
ENSG00000159216.14 | RUNX1 |
RUNX2
|
ENSG00000124813.16 | RUNX2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RUNX1 | hg19_v2_chr21_-_36262032_36262087 | -0.47 | 6.7e-02 | Click! |
RUNX2 | hg19_v2_chr6_+_45390222_45390298 | -0.41 | 1.1e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23241661 | 6.11 |
ENST00000390322.2 |
IGLJ2 |
immunoglobulin lambda joining 2 |
chr4_-_84035868 | 6.04 |
ENST00000426923.2 ENST00000509973.1 |
PLAC8 |
placenta-specific 8 |
chr4_-_84035905 | 5.95 |
ENST00000311507.4 |
PLAC8 |
placenta-specific 8 |
chr17_-_29641104 | 5.03 |
ENST00000577894.1 ENST00000330927.4 |
EVI2B |
ecotropic viral integration site 2B |
chr16_+_85942594 | 4.89 |
ENST00000566369.1 |
IRF8 |
interferon regulatory factor 8 |
chr17_-_29641084 | 4.74 |
ENST00000544462.1 |
EVI2B |
ecotropic viral integration site 2B |
chr11_+_7626950 | 4.28 |
ENST00000530181.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr17_-_34417479 | 3.99 |
ENST00000225245.5 |
CCL3 |
chemokine (C-C motif) ligand 3 |
chr22_+_23247030 | 3.74 |
ENST00000390324.2 |
IGLJ3 |
immunoglobulin lambda joining 3 |
chr2_-_158300556 | 3.52 |
ENST00000264192.3 |
CYTIP |
cytohesin 1 interacting protein |
chr8_-_102803163 | 3.35 |
ENST00000523645.1 ENST00000520346.1 ENST00000220931.6 ENST00000522448.1 ENST00000522951.1 ENST00000522252.1 ENST00000519098.1 |
NCALD |
neurocalcin delta |
chr6_+_31982539 | 3.01 |
ENST00000435363.2 ENST00000425700.2 |
C4B |
complement component 4B (Chido blood group) |
chr1_-_25291475 | 2.94 |
ENST00000338888.3 ENST00000399916.1 |
RUNX3 |
runt-related transcription factor 3 |
chr6_+_31949801 | 2.91 |
ENST00000428956.2 ENST00000498271.1 |
C4A |
complement component 4A (Rodgers blood group) |
chr1_+_209929377 | 2.88 |
ENST00000400959.3 ENST00000367025.3 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
chr1_-_173174681 | 2.87 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr12_-_53594227 | 2.86 |
ENST00000550743.2 |
ITGB7 |
integrin, beta 7 |
chr17_-_34524157 | 2.83 |
ENST00000378354.4 ENST00000394484.1 |
CCL3L3 |
chemokine (C-C motif) ligand 3-like 3 |
chr9_-_116840728 | 2.79 |
ENST00000265132.3 |
AMBP |
alpha-1-microglobulin/bikunin precursor |
chr1_+_198608146 | 2.69 |
ENST00000367376.2 ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
chr17_-_34625719 | 2.68 |
ENST00000422211.2 ENST00000542124.1 |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
chr16_+_23847339 | 2.65 |
ENST00000303531.7 |
PRKCB |
protein kinase C, beta |
chr11_+_121447469 | 2.63 |
ENST00000532694.1 ENST00000534286.1 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
chr1_-_114414316 | 2.57 |
ENST00000528414.1 ENST00000538253.1 ENST00000460620.1 ENST00000420377.2 ENST00000525799.1 ENST00000359785.5 |
PTPN22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr6_+_31543334 | 2.53 |
ENST00000449264.2 |
TNF |
tumor necrosis factor |
chrX_-_70838306 | 2.52 |
ENST00000373691.4 ENST00000373693.3 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
chr4_+_88896819 | 2.47 |
ENST00000237623.7 ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1 |
secreted phosphoprotein 1 |
chr1_+_192544857 | 2.40 |
ENST00000367459.3 ENST00000469578.2 |
RGS1 |
regulator of G-protein signaling 1 |
chr17_-_79008373 | 2.37 |
ENST00000577066.1 ENST00000573167.1 |
BAIAP2-AS1 |
BAIAP2 antisense RNA 1 (head to head) |
chr12_+_25205568 | 2.30 |
ENST00000548766.1 ENST00000556887.1 |
LRMP |
lymphoid-restricted membrane protein |
chr19_-_6720686 | 2.30 |
ENST00000245907.6 |
C3 |
complement component 3 |
chr3_+_113251143 | 2.29 |
ENST00000264852.4 ENST00000393830.3 |
SIDT1 |
SID1 transmembrane family, member 1 |
chr12_+_25205446 | 2.21 |
ENST00000557489.1 ENST00000354454.3 ENST00000536173.1 |
LRMP |
lymphoid-restricted membrane protein |
chr11_+_22696314 | 2.20 |
ENST00000532398.1 ENST00000433790.1 |
GAS2 |
growth arrest-specific 2 |
chr16_+_23847267 | 2.20 |
ENST00000321728.7 |
PRKCB |
protein kinase C, beta |
chr14_-_106092403 | 2.18 |
ENST00000390543.2 |
IGHG4 |
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr2_+_90077680 | 2.16 |
ENST00000390270.2 |
IGKV3D-20 |
immunoglobulin kappa variable 3D-20 |
chr6_-_33048483 | 2.14 |
ENST00000419277.1 |
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
chr16_+_30194916 | 2.12 |
ENST00000570045.1 ENST00000565497.1 ENST00000570244.1 |
CORO1A |
coronin, actin binding protein, 1A |
chr16_+_72088376 | 2.07 |
ENST00000570083.1 ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP HPR |
haptoglobin haptoglobin-related protein |
chr19_-_36233332 | 2.06 |
ENST00000592537.1 ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1 |
IGF-like family receptor 1 |
chr13_-_46756351 | 2.05 |
ENST00000323076.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr19_-_41256207 | 2.01 |
ENST00000598485.2 ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54 |
chromosome 19 open reading frame 54 |
chr6_+_32407619 | 1.97 |
ENST00000395388.2 ENST00000374982.5 |
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
chr2_+_68592305 | 1.95 |
ENST00000234313.7 |
PLEK |
pleckstrin |
chr10_+_114135004 | 1.93 |
ENST00000393081.1 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr2_+_8822113 | 1.93 |
ENST00000396290.1 ENST00000331129.3 |
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
chr1_+_209929494 | 1.90 |
ENST00000367026.3 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
chr12_+_7055631 | 1.90 |
ENST00000543115.1 ENST00000399448.1 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr5_+_75699149 | 1.88 |
ENST00000379730.3 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
chr17_-_62009621 | 1.88 |
ENST00000349817.2 ENST00000392795.3 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
chr5_-_138725594 | 1.81 |
ENST00000302125.8 |
MZB1 |
marginal zone B and B1 cell-specific protein |
chr5_-_138725560 | 1.81 |
ENST00000412103.2 ENST00000457570.2 |
MZB1 |
marginal zone B and B1 cell-specific protein |
chr6_-_11382478 | 1.80 |
ENST00000397378.3 ENST00000513989.1 ENST00000508546.1 ENST00000504387.1 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
chr2_+_127413704 | 1.79 |
ENST00000409836.3 |
GYPC |
glycophorin C (Gerbich blood group) |
chr1_+_111772314 | 1.76 |
ENST00000466741.1 ENST00000477185.2 |
CHI3L2 |
chitinase 3-like 2 |
chr3_-_105588231 | 1.75 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr6_+_32709119 | 1.72 |
ENST00000374940.3 |
HLA-DQA2 |
major histocompatibility complex, class II, DQ alpha 2 |
chr17_+_79935418 | 1.70 |
ENST00000306729.7 ENST00000306739.4 |
ASPSCR1 |
alveolar soft part sarcoma chromosome region, candidate 1 |
chr6_-_32920794 | 1.67 |
ENST00000395305.3 ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA XXbac-BPG181M17.5 |
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
chr16_+_85645007 | 1.67 |
ENST00000405402.2 |
GSE1 |
Gse1 coiled-coil protein |
chr22_-_43411106 | 1.67 |
ENST00000453643.1 ENST00000263246.3 ENST00000337959.4 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
chrX_-_2418936 | 1.65 |
ENST00000461691.1 ENST00000381223.4 ENST00000381222.2 ENST00000412516.2 ENST00000334651.5 |
ZBED1 DHRSX |
zinc finger, BED-type containing 1 dehydrogenase/reductase (SDR family) X-linked |
chr2_-_21266935 | 1.63 |
ENST00000233242.1 |
APOB |
apolipoprotein B |
chr22_+_22988816 | 1.63 |
ENST00000480559.1 ENST00000448514.1 |
GGTLC2 |
gamma-glutamyltransferase light chain 2 |
chr17_+_79935464 | 1.61 |
ENST00000581647.1 ENST00000580534.1 ENST00000579684.1 |
ASPSCR1 |
alveolar soft part sarcoma chromosome region, candidate 1 |
chr3_+_186330712 | 1.61 |
ENST00000411641.2 ENST00000273784.5 |
AHSG |
alpha-2-HS-glycoprotein |
chr4_-_38806404 | 1.60 |
ENST00000308979.2 ENST00000505940.1 ENST00000515861.1 |
TLR1 |
toll-like receptor 1 |
chr22_+_25003626 | 1.60 |
ENST00000451366.1 ENST00000406383.2 ENST00000428855.1 |
GGT1 |
gamma-glutamyltransferase 1 |
chr1_+_111415757 | 1.60 |
ENST00000429072.2 ENST00000271324.5 |
CD53 |
CD53 molecule |
chr11_+_1874200 | 1.59 |
ENST00000311604.3 |
LSP1 |
lymphocyte-specific protein 1 |
chr16_+_27438563 | 1.59 |
ENST00000395754.4 |
IL21R |
interleukin 21 receptor |
chr17_-_10017864 | 1.58 |
ENST00000323816.4 |
GAS7 |
growth arrest-specific 7 |
chr13_-_99959641 | 1.56 |
ENST00000376414.4 |
GPR183 |
G protein-coupled receptor 183 |
chr3_-_98241358 | 1.56 |
ENST00000503004.1 ENST00000506575.1 ENST00000513452.1 ENST00000515620.1 |
CLDND1 |
claudin domain containing 1 |
chr14_+_75988851 | 1.55 |
ENST00000555504.1 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr17_-_40835076 | 1.54 |
ENST00000591765.1 |
CCR10 |
chemokine (C-C motif) receptor 10 |
chr5_+_75699040 | 1.53 |
ENST00000274364.6 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
chrX_-_70331298 | 1.50 |
ENST00000456850.2 ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG |
interleukin 2 receptor, gamma |
chr8_+_11351876 | 1.49 |
ENST00000529894.1 |
BLK |
B lymphoid tyrosine kinase |
chr1_+_111772435 | 1.47 |
ENST00000524472.1 |
CHI3L2 |
chitinase 3-like 2 |
chr16_+_56965960 | 1.46 |
ENST00000439977.2 ENST00000344114.4 ENST00000300302.5 ENST00000379792.2 |
HERPUD1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
chr7_+_116660246 | 1.44 |
ENST00000434836.1 ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7 |
suppression of tumorigenicity 7 |
chr4_-_71532339 | 1.44 |
ENST00000254801.4 |
IGJ |
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr4_+_74269956 | 1.43 |
ENST00000295897.4 ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB |
albumin |
chr13_-_46964177 | 1.43 |
ENST00000389908.3 |
KIAA0226L |
KIAA0226-like |
chr7_+_134832808 | 1.43 |
ENST00000275767.3 |
TMEM140 |
transmembrane protein 140 |
chr6_-_137540477 | 1.42 |
ENST00000367735.2 ENST00000367739.4 ENST00000458076.1 ENST00000414770.1 |
IFNGR1 |
interferon gamma receptor 1 |
chr21_-_46348694 | 1.41 |
ENST00000355153.4 ENST00000397850.2 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr15_-_72668185 | 1.40 |
ENST00000457859.2 ENST00000566304.1 ENST00000567159.1 ENST00000429918.2 |
HEXA |
hexosaminidase A (alpha polypeptide) |
chr17_-_62009702 | 1.40 |
ENST00000006750.3 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
chr22_-_21580582 | 1.39 |
ENST00000424627.1 |
GGT2 |
gamma-glutamyltransferase 2 |
chr16_-_28608364 | 1.39 |
ENST00000533150.1 |
SULT1A2 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 |
chr3_-_170744498 | 1.38 |
ENST00000382808.4 ENST00000314251.3 |
SLC2A2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
chr17_-_26695013 | 1.37 |
ENST00000555059.2 |
CTB-96E2.2 |
Homeobox protein SEBOX |
chr11_-_2162468 | 1.37 |
ENST00000434045.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr21_+_42733870 | 1.36 |
ENST00000330714.3 ENST00000436410.1 ENST00000435611.1 |
MX2 |
myxovirus (influenza virus) resistance 2 (mouse) |
chr20_-_23967432 | 1.36 |
ENST00000286890.4 ENST00000278765.4 |
GGTLC1 |
gamma-glutamyltransferase light chain 1 |
chr22_+_23264766 | 1.36 |
ENST00000390331.2 |
IGLC7 |
immunoglobulin lambda constant 7 |
chr8_+_11351494 | 1.35 |
ENST00000259089.4 |
BLK |
B lymphoid tyrosine kinase |
chr17_-_26694979 | 1.33 |
ENST00000438614.1 |
VTN |
vitronectin |
chr6_-_41168920 | 1.33 |
ENST00000483722.1 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
chrX_+_48542168 | 1.31 |
ENST00000376701.4 |
WAS |
Wiskott-Aldrich syndrome |
chr15_-_72668805 | 1.29 |
ENST00000268097.5 |
HEXA |
hexosaminidase A (alpha polypeptide) |
chrX_+_84258832 | 1.26 |
ENST00000373173.2 |
APOOL |
apolipoprotein O-like |
chr14_-_106573756 | 1.25 |
ENST00000390601.2 |
IGHV3-11 |
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr17_-_7017559 | 1.25 |
ENST00000446679.2 |
ASGR2 |
asialoglycoprotein receptor 2 |
chr19_+_1067492 | 1.24 |
ENST00000586866.1 |
HMHA1 |
histocompatibility (minor) HA-1 |
chr17_-_40833858 | 1.24 |
ENST00000332438.4 |
CCR10 |
chemokine (C-C motif) receptor 10 |
chr1_-_9129735 | 1.23 |
ENST00000377424.4 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr20_+_61299155 | 1.21 |
ENST00000451793.1 |
SLCO4A1 |
solute carrier organic anion transporter family, member 4A1 |
chr14_+_64680854 | 1.21 |
ENST00000458046.2 |
SYNE2 |
spectrin repeat containing, nuclear envelope 2 |
chr18_+_13611763 | 1.21 |
ENST00000585931.1 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
chr11_+_1889880 | 1.19 |
ENST00000405957.2 |
LSP1 |
lymphocyte-specific protein 1 |
chrX_-_102319092 | 1.19 |
ENST00000372728.3 |
BEX1 |
brain expressed, X-linked 1 |
chr4_+_128554081 | 1.18 |
ENST00000335251.6 ENST00000296461.5 |
INTU |
inturned planar cell polarity protein |
chr1_+_160709055 | 1.18 |
ENST00000368043.3 ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7 |
SLAM family member 7 |
chr11_+_7534999 | 1.18 |
ENST00000528947.1 ENST00000299492.4 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr1_+_160709029 | 1.17 |
ENST00000444090.2 ENST00000441662.2 |
SLAMF7 |
SLAM family member 7 |
chr19_+_41882598 | 1.17 |
ENST00000447302.2 ENST00000544232.1 ENST00000542945.1 ENST00000540732.1 |
TMEM91 CTC-435M10.3 |
transmembrane protein 91 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial; Uncharacterized protein |
chr2_+_143886877 | 1.17 |
ENST00000295095.6 |
ARHGAP15 |
Rho GTPase activating protein 15 |
chr11_+_121322832 | 1.17 |
ENST00000260197.7 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
chr3_+_98250743 | 1.16 |
ENST00000284311.3 |
GPR15 |
G protein-coupled receptor 15 |
chrX_-_40036520 | 1.16 |
ENST00000406200.2 ENST00000378455.4 ENST00000342274.4 |
BCOR |
BCL6 corepressor |
chr5_-_111091948 | 1.15 |
ENST00000447165.2 |
NREP |
neuronal regeneration related protein |
chr17_+_72462766 | 1.14 |
ENST00000392625.3 ENST00000361933.3 ENST00000310828.5 |
CD300A |
CD300a molecule |
chr16_+_57392684 | 1.13 |
ENST00000219235.4 |
CCL22 |
chemokine (C-C motif) ligand 22 |
chr1_+_32930647 | 1.13 |
ENST00000609129.1 |
ZBTB8B |
zinc finger and BTB domain containing 8B |
chr2_-_64881018 | 1.12 |
ENST00000313349.3 |
SERTAD2 |
SERTA domain containing 2 |
chr14_-_90085458 | 1.12 |
ENST00000345097.4 ENST00000555855.1 ENST00000555353.1 |
FOXN3 |
forkhead box N3 |
chr6_+_167704838 | 1.11 |
ENST00000366829.2 |
UNC93A |
unc-93 homolog A (C. elegans) |
chr14_+_100531615 | 1.11 |
ENST00000392920.3 |
EVL |
Enah/Vasp-like |
chr17_-_64216748 | 1.11 |
ENST00000585162.1 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr15_+_58724184 | 1.09 |
ENST00000433326.2 |
LIPC |
lipase, hepatic |
chr1_-_9129598 | 1.08 |
ENST00000535586.1 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr1_-_207095324 | 1.07 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr2_-_89442621 | 1.07 |
ENST00000492167.1 |
IGKV3-20 |
immunoglobulin kappa variable 3-20 |
chr16_-_28608424 | 1.07 |
ENST00000335715.4 |
SULT1A2 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 |
chr1_-_168513229 | 1.07 |
ENST00000367819.2 |
XCL2 |
chemokine (C motif) ligand 2 |
chr22_+_44464923 | 1.06 |
ENST00000404989.1 |
PARVB |
parvin, beta |
chr17_-_56494908 | 1.05 |
ENST00000577716.1 |
RNF43 |
ring finger protein 43 |
chr6_+_292051 | 1.05 |
ENST00000344450.5 |
DUSP22 |
dual specificity phosphatase 22 |
chr17_-_7018128 | 1.04 |
ENST00000380952.2 ENST00000254850.7 |
ASGR2 |
asialoglycoprotein receptor 2 |
chr6_+_13272904 | 1.04 |
ENST00000379335.3 ENST00000379329.1 |
PHACTR1 |
phosphatase and actin regulator 1 |
chr14_+_75988768 | 1.03 |
ENST00000286639.6 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr17_-_56494882 | 1.03 |
ENST00000584437.1 |
RNF43 |
ring finger protein 43 |
chr12_+_7055767 | 1.02 |
ENST00000447931.2 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr5_-_42811986 | 1.02 |
ENST00000511224.1 ENST00000507920.1 ENST00000510965.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr20_-_62199427 | 1.02 |
ENST00000427522.2 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
chr14_-_94854926 | 1.02 |
ENST00000402629.1 ENST00000556091.1 ENST00000554720.1 |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr15_-_20193370 | 1.01 |
ENST00000558565.2 |
IGHV3OR15-7 |
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr1_+_17866290 | 1.01 |
ENST00000361221.3 ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr5_+_156696362 | 1.00 |
ENST00000377576.3 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr2_-_175462456 | 1.00 |
ENST00000409891.1 ENST00000410117.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr17_+_25958174 | 0.99 |
ENST00000313648.6 ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9 |
lectin, galactoside-binding, soluble, 9 |
chr13_+_113622810 | 0.99 |
ENST00000397030.1 |
MCF2L |
MCF.2 cell line derived transforming sequence-like |
chr15_+_75080883 | 0.98 |
ENST00000567571.1 |
CSK |
c-src tyrosine kinase |
chr1_-_159046617 | 0.98 |
ENST00000368130.4 |
AIM2 |
absent in melanoma 2 |
chr5_-_42812143 | 0.98 |
ENST00000514985.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chrX_+_115567767 | 0.97 |
ENST00000371900.4 |
SLC6A14 |
solute carrier family 6 (amino acid transporter), member 14 |
chr19_+_36203830 | 0.97 |
ENST00000262630.3 |
ZBTB32 |
zinc finger and BTB domain containing 32 |
chr15_+_41057818 | 0.97 |
ENST00000558467.1 |
GCHFR |
GTP cyclohydrolase I feedback regulator |
chr17_-_56494713 | 0.97 |
ENST00000407977.2 |
RNF43 |
ring finger protein 43 |
chr19_-_10445399 | 0.97 |
ENST00000592945.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr7_+_99971129 | 0.97 |
ENST00000394000.2 ENST00000350573.2 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
chr2_+_24714729 | 0.96 |
ENST00000406961.1 ENST00000405141.1 |
NCOA1 |
nuclear receptor coactivator 1 |
chr17_-_16875371 | 0.95 |
ENST00000437538.2 ENST00000583789.1 ENST00000261652.2 ENST00000579315.1 |
TNFRSF13B |
tumor necrosis factor receptor superfamily, member 13B |
chr11_-_117699413 | 0.95 |
ENST00000528014.1 |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
chr19_-_51875894 | 0.94 |
ENST00000600427.1 ENST00000595217.1 ENST00000221978.5 |
NKG7 |
natural killer cell group 7 sequence |
chr22_+_24823517 | 0.94 |
ENST00000496258.1 ENST00000337539.7 |
ADORA2A |
adenosine A2a receptor |
chr10_-_65028938 | 0.94 |
ENST00000402544.1 |
JMJD1C |
jumonji domain containing 1C |
chr7_-_100844193 | 0.94 |
ENST00000440203.2 ENST00000379423.3 ENST00000223114.4 |
MOGAT3 |
monoacylglycerol O-acyltransferase 3 |
chr7_-_29234802 | 0.93 |
ENST00000449801.1 ENST00000409850.1 |
CPVL |
carboxypeptidase, vitellogenic-like |
chr10_-_65028817 | 0.93 |
ENST00000542921.1 |
JMJD1C |
jumonji domain containing 1C |
chr2_-_175462934 | 0.93 |
ENST00000392546.2 ENST00000436221.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr9_+_117092149 | 0.93 |
ENST00000431067.2 ENST00000412657.1 |
ORM2 |
orosomucoid 2 |
chr2_+_11752379 | 0.93 |
ENST00000396123.1 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr6_+_107811162 | 0.93 |
ENST00000317357.5 |
SOBP |
sine oculis binding protein homolog (Drosophila) |
chr11_+_108093559 | 0.91 |
ENST00000278616.4 |
ATM |
ataxia telangiectasia mutated |
chr14_-_94789663 | 0.91 |
ENST00000557225.1 ENST00000341584.3 |
SERPINA6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
chr20_+_61448376 | 0.91 |
ENST00000343916.3 |
COL9A3 |
collagen, type IX, alpha 3 |
chr1_+_158801095 | 0.90 |
ENST00000368141.4 |
MNDA |
myeloid cell nuclear differentiation antigen |
chr3_+_42947600 | 0.90 |
ENST00000328199.6 ENST00000541208.1 |
ZNF662 |
zinc finger protein 662 |
chr22_+_21133469 | 0.90 |
ENST00000406799.1 |
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr16_-_28621353 | 0.89 |
ENST00000567512.1 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr14_-_106994333 | 0.89 |
ENST00000390624.2 |
IGHV3-48 |
immunoglobulin heavy variable 3-48 |
chr6_+_31916733 | 0.89 |
ENST00000483004.1 |
CFB |
complement factor B |
chr1_-_9129895 | 0.89 |
ENST00000473209.1 |
SLC2A5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
chr12_+_81471816 | 0.89 |
ENST00000261206.3 |
ACSS3 |
acyl-CoA synthetase short-chain family member 3 |
chr5_-_108745689 | 0.89 |
ENST00000361189.2 |
PJA2 |
praja ring finger 2, E3 ubiquitin protein ligase |
chr3_-_98241760 | 0.88 |
ENST00000507874.1 ENST00000502299.1 ENST00000508659.1 ENST00000510545.1 ENST00000511667.1 ENST00000394185.2 ENST00000394181.2 ENST00000508902.1 ENST00000341181.6 ENST00000437922.1 ENST00000394180.2 |
CLDND1 |
claudin domain containing 1 |
chr14_-_106330458 | 0.88 |
ENST00000461719.1 |
IGHJ4 |
immunoglobulin heavy joining 4 |
chr1_+_32716840 | 0.87 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr12_-_719573 | 0.86 |
ENST00000397265.3 |
NINJ2 |
ninjurin 2 |
chr3_-_187454281 | 0.86 |
ENST00000232014.4 |
BCL6 |
B-cell CLL/lymphoma 6 |
chr7_+_102715315 | 0.86 |
ENST00000428183.2 ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10 |
armadillo repeat containing 10 |
chr15_-_37393406 | 0.86 |
ENST00000338564.5 ENST00000558313.1 ENST00000340545.5 |
MEIS2 |
Meis homeobox 2 |
chr12_-_110434096 | 0.85 |
ENST00000320063.9 ENST00000457474.2 ENST00000547815.1 ENST00000361006.5 |
GIT2 |
G protein-coupled receptor kinase interacting ArfGAP 2 |
chr17_-_26903900 | 0.85 |
ENST00000395319.3 ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC |
aldolase C, fructose-bisphosphate |
chr12_+_71833550 | 0.85 |
ENST00000266674.5 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 5.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 6.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 9.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 10.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 3.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 6.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 4.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 4.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 4.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 3.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 4.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 2.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 9.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 7.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 5.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 1.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 13.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 8.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 4.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 4.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 7.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 3.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 2.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 2.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.3 | 3.8 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
1.2 | 5.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.2 | 3.5 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.1 | 3.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.0 | 1.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
1.0 | 2.9 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.9 | 3.6 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.9 | 3.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.9 | 2.6 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.8 | 2.5 | GO:0035938 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.8 | 3.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.7 | 2.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.7 | 2.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 2.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.6 | 4.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 10.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.8 | GO:0042495 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.6 | 4.0 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.5 | 1.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.5 | 1.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 1.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.5 | 1.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.4 | 1.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.4 | 6.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.4 | 4.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 2.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.4 | 1.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.4 | 4.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.3 | 0.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 2.0 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.3 | 1.0 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.3 | 1.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.3 | 0.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 3.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.3 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.3 | 0.9 | GO:1904884 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.3 | 2.0 | GO:0010269 | response to selenium ion(GO:0010269) |
0.3 | 0.8 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 0.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) glycoside transport(GO:1901656) cellular response to bile acid(GO:1903413) |
0.3 | 1.4 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.3 | 0.8 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.3 | 1.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
0.3 | 0.8 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.2 | 6.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 2.3 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.2 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.7 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 0.4 | GO:0033135 | regulation of peptidyl-serine phosphorylation(GO:0033135) positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.9 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
0.2 | 0.6 | GO:0003285 | septum secundum development(GO:0003285) |
0.2 | 1.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.6 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.2 | 0.8 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.2 | 1.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 0.6 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 1.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 4.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.5 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 3.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.5 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.2 | 2.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 1.7 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.2 | 2.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.2 | 0.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.2 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 0.5 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
0.2 | 1.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 1.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 3.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.1 | 1.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.4 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 2.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.5 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.1 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 1.4 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.4 | GO:2000437 | monocyte extravasation(GO:0035696) activation of meiosis(GO:0090427) regulation of monocyte extravasation(GO:2000437) |
0.1 | 1.7 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.1 | 1.7 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 2.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 1.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 2.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 1.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.7 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 1.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 1.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.1 | 2.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.3 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 1.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 8.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 1.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 7.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.6 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
0.1 | 0.2 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.1 | 1.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.2 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.1 | 0.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 1.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.1 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) negative regulation of complement-dependent cytotoxicity(GO:1903660) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 1.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 2.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.0 | 1.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 4.3 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.0 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0071864 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.4 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:1902527 | fat pad development(GO:0060613) positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0035726 | myeloid progenitor cell differentiation(GO:0002318) common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 3.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 2.2 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.2 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.0 | 2.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 3.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.5 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.0 | 0.1 | GO:0072237 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) metanephric proximal tubule development(GO:0072237) |
0.0 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 1.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.0 | 0.2 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.2 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 1.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 1.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 2.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.0 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.2 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.0 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.2 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.0 | 0.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.0 | 0.1 | GO:0001707 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.0 | 0.1 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 1.2 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.0 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.0 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.1 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.1 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.0 | 0.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.1 | GO:0009308 | amine metabolic process(GO:0009308) |
0.0 | 0.0 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.4 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.6 | 1.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.5 | 3.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 7.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.1 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.4 | 7.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.3 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 1.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.3 | 4.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 2.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.9 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 0.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.5 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 0.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 14.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 2.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 4.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.7 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.4 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 6.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.5 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 12.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 3.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 7.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 2.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.7 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 1.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.0 | 0.9 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 2.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.4 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 1.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.9 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.2 | GO:0016580 | Sin3 complex(GO:0016580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 9.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 2.5 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 1.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 4.0 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.5 | 1.5 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.5 | 3.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.5 | 1.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 6.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 3.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 5.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 1.7 | GO:0004803 | transposase activity(GO:0004803) |
0.4 | 1.6 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 2.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 2.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 1.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.3 | 1.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 3.4 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.3 | 1.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 0.8 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.3 | 1.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.8 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 8.6 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 3.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 2.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 1.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.5 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 0.9 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 3.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 2.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 2.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 0.6 | GO:0035276 | aldehyde oxidase activity(GO:0004031) ethanol binding(GO:0035276) |
0.1 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 1.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.3 | GO:0051731 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 5.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.5 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 1.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 4.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 2.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 3.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.9 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.2 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 1.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 6.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 1.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 4.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 3.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 4.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 1.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 4.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 2.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 1.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 2.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 3.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 3.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 1.1 | GO:0032934 | cholesterol binding(GO:0015485) sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 3.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 1.1 | GO:0044212 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 3.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 5.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 0.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |